Cover Image
市場調查報告書

免疫化學試劑,分析設備,檢測套組的全球市場:2016年∼2026年

Immunochemistry Reagents, Analysers and Test Kits Market 2016-2026: Disease Specific, Rapid, Toxicology, Endocrinology, Therapeutic Drug Monitoring, Anaemia/Vitamin, Infectious Disease & Autoimmune Disease Tests, Tumour/Cardiac Markers

出版商 Visiongain Ltd 商品編碼 265354
出版日期 內容資訊 英文 160 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
免疫化學試劑,分析設備,檢測套組的全球市場:2016年∼2026年 Immunochemistry Reagents, Analysers and Test Kits Market 2016-2026: Disease Specific, Rapid, Toxicology, Endocrinology, Therapeutic Drug Monitoring, Anaemia/Vitamin, Infectious Disease & Autoimmune Disease Tests, Tumour/Cardiac Markers
出版日期: 2016年10月19日 內容資訊: 英文 160 Pages
簡介

本報告提供全球免疫化學試劑,分析設備,檢測套組市場相關調查分析,概要,市場預測,次市場預測,各地區的市場預測,主要企業等系統性資訊。

第1章 摘要整理

第2章 簡介

  • 所謂體外診斷 (IVD) 檢驗
  • IVD檢驗的種類
  • 免疫系統
  • 多克隆抗體、單株抗體
  • IVD產品的法規

第3章 全球免疫化學市場

  • 全球免疫化學市場
  • 全球免疫化學市場預測
  • 全球免疫化學市場趨勢
  • 免疫化學推動市場要素、阻礙因素

第4章 全球免疫化學試劑、檢測套組市場

  • 所謂免疫化學試劑、檢測套組
  • 全球免疫化學試劑、檢測套組市場:各市場區隔
  • 全球免疫化學試劑、檢測套組市場預測:各市場區隔
  • 疾病特定檢驗市場
  • 迅速檢驗
  • 藥物濫用
  • 內分泌檢查市場
  • 藥物治療監測 (TDM)
  • 貧血/維他命檢驗市場

第5章 全球免疫化學分析儀市場

  • 所謂免疫化學分析儀
  • 免疫化學分析儀市場
  • 免疫化學分析儀市場預測:各市場區隔
  • 免疫化學分析儀市場趨勢

第6章 主要國家的免疫化學市場

  • 全球免疫化學市場各地區明細
  • 全球免疫化學市場:各地區預測
  • 美國
  • 歐洲
  • 日本
  • 中國

第7章 免疫化學市場主要企業

  • Roche
  • Siemens
  • Abbott Laboratories (現在:Abbott and AbbVie)
  • Danaher
  • Ortho Clinical Diagnostics
  • bioMerieux

第8章 免疫化學市場SWOT分析

  • 優勢
  • 弱點
  • 機會
  • 威脅

第9章 結論

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0148

Where is the immunochemistry reagents, analysers and test kits market heading?

Visiongain's new 160-page report provides revenue forecasts to 2026 for the global immunochemistry market, 11 leading submarkets and 9 leading national markets.

This report forecasts the size of the immunochemistry market in the US, Japan, EU5: (Germany, France, Italy, Spain, UK), China, India, and the Rest of the World.

Along with revenue prediction for the overall world market, you see forecasts to 2026 for these submarkets:

  • Immunochemistry reagents and tests kits
  • Immunochemistry analysers

The study also forecasts immunochemistry reagents and tests kits subsectors:

  • Anaemia/Vitamin tests
  • Disease specific tests
  • Drugs of abuse/toxicology tests
  • Therapeutic drug monitoring
  • Endocrinology tests
  • Rapid tests

image1

Our report provides revenues to 2026 for the sub-segments of the immunochemistry analysers, which includes:

  • Chemiluminescence analysers
  • ELISA analysers
  • Immunofluorescence analysers
  • Radioimmunoassay analysers

Assessments of the leading companies in the immunochemistry market - you find activities, products, capabilities and outlooks:

  • Roche
  • Siemens
  • Abbott
  • Danaher
  • Ortho Clinical Diagnostics
  • bioMerieux

Analysis of what stimulates and restrains the industry and market - assessments of challenges and strengths

Table of Contents

1. Executive Summary

  • 1.1 Sector Highlights
  • 1.2 Why You Should Read this Report
  • 1.3 How this Study Delivers Information
  • 1.4 Main Questions Answered by Our Analysis
  • 1.5 Who is This Report For?
  • 1.6 Research and Analysis Methods
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports

2. Introduction

  • 2.1 What are In Vitro Diagnostic (IVD) Tests?
  • 2.2 Types of IVD Tests
    • 2.2.1 Point of Care Tests
    • 2.2.2 Clinical Chemistry
    • 2.2.3 Haematology
    • 2.2.4 Microbiology
    • 2.2.5 Genetic Testing
    • 2.2.6 Immunochemistry
  • 2.3 The Immune System
    • 2.3.1 What is an Antigen?
    • 2.3.2 What is an Antibody?
    • 2.3.3 Antigen-Antibody Interaction
    • 2.3.4 Affinity and Avidity of Antigen-Antibody Interactions
  • 2.4 Polyclonal and Monoclonal Antibodies
  • 2.5 Regulation of IVD Products
    • 2.5.1 Regulation of IVD Products in the US
    • 2.5.2 Regulation of IVD in the EU
    • 2.5.3 Regulation of Laboratory Developed Tests

3. The Global Immunochemistry Market, 2016-2026

  • 3.1 The Global Immunochemistry Market, 2016-2026
  • 3.2 Global Immunochemistry Market Forecast, 2015-2026
  • 3.3. Global Immunochemistry Market Trends, 2015-2026
    • 3.3.1 High Demand Due to Increase in Chronic Patient Population
    • 3.3.2 Automation of Laboratory Systems
    • 3.3.3 Shift towards Decentralisation
    • 3.3.4 Industry Consolidation
    • 3.3.5 Investments by Private Equity/Venture Capital
    • 3.3.6 Increased Awareness through Globalisation
  • 3.4 Immunochemistry Market Drivers and Restraints, 2015-2026

4. Global Immunochemistry Reagents and Test Kits Market, 2015-2026

  • 4.1 Introduction to Immunochemistry Reagents and Test Kits
  • 4.2 Global Immunochemistry Reagents and Test Kits Market by Segment, 2016
  • 4.3 Global Immunochemistry Reagents and Test Kits Market Forecast by Segment, 2016-2026
  • 4.4 Disease Specific Tests Market
    • 4.4.1 Disease Specific Tests Market by Segment, 2016
    • 4.4.2 Disease Specific Tests Market Forecast by Segment, 2015-2026
    • 4.4.3 Disease Specific Tests Market: Drivers and Restraints, 2015-2026
    • 4.4.4 Infectious Diseases
      • 4.4.4.1 Prevalence of Infectious Diseases
      • 4.4.4.2 Infectious Disease Tests Market Forecast 2015-2026
      • 4.4.4.3 Infectious Disease Tests Market Trends, 2015-2026
    • 4.4.5 Autoimmune Diseases
      • 4.4.5.1 Autoimmune Disease Tests Market Forecast 2015-2026
      • 4.4.5.2 Autoimmune Disease Tests Market Trends, 2015-2026
    • 4.4.6 Cancer and Tumour Markers
      • 4.4.6.1 What are Tumour Markers?
        • 4.4.6.1.1 Common Tumour Markers
      • 4.4.6.2 Tumour Marker Market Forecast 2015-2026
      • 4.4.6.3 Tumour Marker Market Trends, 2015-2026
    • 4.4.7 Cardiovascular Diseases and Cardiac Markers
      • 4.4.7.1 Prevalence of Cardiovascular Diseases
      • 4.4.7.2 Common Cardiac Markers
      • 4.4.7.3 Cardiac Marker Market Forecast 2015-2026
      • 4.4.7.4 Cardiac Marker Market Trends, 2015-2026
    • 4.4.8 Allergic Blood Tests
      • 4.4.8.1 Prevalence of Allergy
      • 4.4.8.2 Allergic Blood Tests Market Forecast 2015-2026
      • 4.4.8.3 Allergic Blood Tests Market Trends, 2015-2026
      • 4.4.8.4 Leading Allergy Testing Auto-Analysers, 2016
      • 4.4.8.5 Allergy Blood Testing Dominated by Phadia (Part of Thermo Fisher)
  • 4.5 Rapid Tests
    • 4.5.1 Rapid Tests Market, 2015
    • 4.5.2 Rapid Tests Market Forecast 2015-2026
    • 4.5.3 Rapid Tests Market Trends, 2015-2026
    • 4.5.4 Rapid Tests Market: Drivers and Restraints, 2015-2026
  • 4.6 Drugs of Abuse
    • 4.6.1 Extent of Illicit Drug Use
    • 4.6.2 Common Drugs of Abuse
    • 4.6.3 Drugs of Abuse/Toxicology Tests Market Forecast, 2015-2026
    • 4.6.4 Drugs of Abuse/Toxicology Tests Market Trends, 2015-2026
    • 4.6.5 Drugs of Abuse Tests Market: Drivers and Restraints, 2015-2026
  • 4.7 Endocrinology Tests Market, 2015
    • 4.7.1 Endocrinology Tests Market Forecast by Segment, 2015-2026
    • 4.7.2 Trends in the Endocrinology Tests Market, 2015-2026
    • 4.7.3 Endocrinology Tests Market: Drivers and Restraints, 2015-2026
  • 4.8 Therapeutic Drug Monitoring
    • 4.8.1 Commonly Monitored Drugs
      • 4.8.1.1 Antiepileptics
      • 4.8.1.2 Antiarrhythmics
      • 4.8.1.3 Antibiotics
      • 4.8.1.4 Immunosuppressants
      • 4.8.1.5 Bronchodilators
      • 4.8.1.6 Antimanics
    • 4.8.2 Therapeutic Drug Monitoring Market, 2015
    • 4.8.3 Immunoassays Preferred Over Chromatographic Methods for TDM
    • 4.8.4 Therapeutic Drug Monitoring Market Forecast 2015-2026
    • 4.8.5 Therapeutic Drug Monitoring Market Trends, 2015-2026
    • 4.8.6 Therapeutic Drug Monitoring Market: Drivers and Restraints, 2015-2026
  • 4.9 Anaemia/Vitamin Tests Market, 2015
    • 4.9.1 What is Anaemia?
    • 4.9.2 Types of Anaemia
      • 4.9.2.1 Iron Deficiency Anaemia (IDA)
      • 4.9.2.2 Vitamin Deficiency in Anaemia
    • 4.9.3 Diagnosis of Vitamin B12 Deficiency and Folic Acid Deficiency
    • 4.9.4 Vitamin D Deficiency Affects a Large Population Worldwide
    • 4.9.5 Diagnosis of Vitamin D Deficiency
      • 4.9.5.1 Immunoassays for Vitamin D Measurement
    • 4.9.6 Anaemia/ Vitamin Tests Market Forecast 2015-2026
    • 4.9.7 Anaemia/Vitamin Tests Market Trends, 2015-2026
    • 4.9.8 Regulatory Approvals
    • 4.9.9 Anaemia/Vitamin Tests Market: Drivers and Restraints, 2015-2026

5. Global Immunochemistry Analysers Market, 2015-2026

  • 5.1 Introduction to Immunochemistry Analysers
    • 5.1.1 Radioimmunoassay Analysers
    • 5.1.2 Enzyme Immunoassay Analysers
    • 5.1.3 Immunofluorescence Analysers
    • 5.1.4 Chemiluminescence Analysers
  • 5.2 Immunochemistry Analysers Market, 2015
  • 5.3 Immunochemistry Analysers Market Forecast by Segment, 2015-2026
  • 5.4 Immunochemistry Analysers Market Trends, 2015-2026

6. Leading National Immunochemistry Markets, 2016-2026

  • 6.1 Regional Breakdown of the Global Immunochemistry Market, 2015
  • 6.2 Global Immunochemistry Market: Regional Forecast, 2015-2026
  • 6.3 The US Market
    • 6.3.1 The US Market: Growth Drivers
      • 6.3.1.1 Increasing Prevalence of Chronic Diseases
      • 6.3.1.2 Strong Growth in the Drugs of Abuse Market
    • 6.3.2 The US Market: Growth Restraints
      • 6.3.2.1 Medical Device Excise Tax
  • 6.4 The European Market
    • 6.4.1 Germany and France
    • 6.4.2 The Italian Market
    • 6.4.3 The Spanish Market
    • 6.4.4 The UK Market
  • 6.5 The Japanese Market
  • 6.6 The Chinese Market

7. Leading Companies in the Immunochemistry Market, 2015

  • 7.1 Roche
    • 7.1.1 Sales and Performance Analysis, 2015
    • 7.1.2 Roche Diagnostics
    • 7.1.3 Investment in Research and Development
    • 7.1.4 Historical Product Launches in the Immunochemistry Market
    • 7.1.5 Construction of New Diagnostic Production Facility
    • 7.1.6 Roche: Immunochemistry Analysers
    • 7.1.6.1 Cobas 8000 Analyser
    • 7.1.6.2 Cobas 6000 Analyser
    • 7.1.6.3 Cobas 4000 Analyser
  • 7.2 Siemens
    • 7.2.1 Sales and Performance Analysis, 2015
    • 7.2.2 Siemens Healthcare Sector, 2015
    • 7.2.3 Siemens: R&D Expenses, 2015
    • 7.2.4 Siemens: Immunochemistry Analysers
      • 7.2.4.1 Dimension Vista Systems
      • 7.2.4.2 Advia Centaur XP Immunoassay System
      • 7.2.4.3 Advia Centaur CP Immunoassay System
      • 7.2.4.4 Immulite Series
        • 7.2.4.4.1 Immulite 2000 Immunoassay System
        • 7.2.4.4.2 Immulite 1000 Immunoassay System
  • 7.3 Abbott Laboratories (Now Abbott and AbbVie)
    • 7.3.1 Sales and Performance Analysis, 2015
    • 7.3.2 Abbott: Immunochemistry Analysers
      • 7.3.2.1 Abbott Prism
      • 7.3.2.2 Architect ci8200
      • 7.3.2.3 Architect ci16200
      • 7.3.2.4 Architect ci4100
  • 7.4 Danaher
    • 7.4.1 Sales and Performance Analysis, 2015
    • 7.4.2 Life Sciences & Diagnostics
    • 7.4.3 Danaher: Immunochemistry Analysers
  • 7.5 Ortho Clinical Diagnostics (formerly part of Johnson & Johnson)
    • 7.5.1 Sales and Performance Analysis, 2015
    • 7.5.2 Ortho Clinical Diagnostics: Immunodiagnostic Analysers
  • 7.6 bioMérieux
    • 7.6.1 Sales and Performance Analysis, 2015
    • 7.6.2 Breakdown of Sales by Technology, 2015
    • 7.6.3 bioMérieux: Recent Collaborations
      • 7.6.3.1 Collaboration with Royal Philips Electronics
      • 7.6.3.2 Collaboration with Hospices Civils De Lyon

8. SWOT Analysis of the Immunochemistry Market, 2016-2026

  • 8.1 Strengths
    • 8.1.1 Patient Demographics
    • 8.1.2 Automation and Other Technological Advancements
    • 8.1.3 IVD Tests are Vital for Disease Management
    • 8.1.4 Mature Market
  • 8.2 Weaknesses
    • 8.2.1 Regulatory Board Approval
    • 8.2.2 Reimbursement Issues
  • 8.3 Opportunities
    • 8.3.1 Globalisation
  • 8.4 Threats
    • 8.4.1 Medical Device Excise Tax
    • 8.4.2 Regulatory Issues - Lack of Clarity Can be Costly

9. Conclusions

  • 9.1 The Immunochemistry Market - Driven by the Reagents and Test Kits Market
  • 9.2 Rapid Tests Will Remain the Fastest Growing Segment
  • 9.3 The US was the Leading National Market in 2015
  • 9.4 Future Outlook and Concluding Remarks
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form

List of Table

  • Table 1.1 (Sample) Global Immunochemistry Market Forecast ($bn), (%), 2015-2026
  • Table 3.1 Immunochemistry Market: Revenue ($bn) and Market Shares (%) by Segment, 2016
  • Table 3.2 Global Immunochemistry Market Forecast ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 3.3 Key Mergers & Acquisition Deals, 2011-2016
  • Table 3.4 Immunochemistry Market: Drivers and Restraints, 2015-2026
  • Table 4.1 Global Immunochemistry Reagents and Test Kits Market: Revenue ($bn) and Market Shares (%) by Segment, 2016
  • Table 4.2 Global Immunochemistry Reagents and Test Kits Market Forecast by Segment ($bn), AGR(%), CAGR(%), 2015-2026
  • Table 4.3 Disease Specific Tests Market: Revenue ($bn) and Market Shares (%) by Segment, 2016
  • Table 4.4 Disease Specific Tests Market Forecast by Segment ($bn), AGR(%), CAGR(%), 2015-2026
  • Table 4.5 Disease Specific Tests Market: Drivers and Restraints, 2015-2026
  • Table 4.6 Common Tumour Markers Used in Diagnosis, 2016
  • Table 4.7 Common Cardiac Markers Used in Diagnosis, 2016
  • Table 4.8 Leading Allergy Testing Auto Analysers, 2016
  • Table 4.9 Rapid Tests Market: Drivers and Restraints, 2015-2026
  • Table 4.10 Common Drugs of Abuse, 2016
  • Table 4.10.1 (Contd) Common Drugs of Abuse, 2016
  • Table 4.11 Drugs of Abuse Market: Drivers and Restraints, 2015-2026
  • Table 4.12 Commonly Monitored Endocrine Hormones
  • Table 4.13 Endocrinology Tests: Revenue ($m) and Market Shares (%) by Segment, 2015
  • Table 4.14 Endocrinology Tests Market Forecast by Segment ($m), AGR(%), CAGR(%), 2015-2026
  • Table 4.15 Endocrinology Tests Market: Drivers and Restraints, 2015-2026
  • Table 4.16 Therapeutic Drug Monitoring Market: Drivers and Restraints, 2015-2026
  • Table 4.17 Anaemia/Vitamin Tests Market: Drivers and Restraints, 2015-2026
  • Table 5.1 Immunochemistry Analysers Market: Revenue ($bn) and Market Shares (%) by Segment, 2015
  • Table 5.2 Immunochemistry Analysers Market Forecast ($bn), AGR (%) and CAGR (%) by Segment, 2015-2026
  • Table 6.1 Leading National Immunochemistry Markets: Revenue ($bn) and Market Shares (%), 2015
  • Table 6.2 Global Immunochemistry Market Forecast ($bn), AGR(%) and CAGR (%) by Leading National Markets, 2015-2026
  • Table 6.3 The Leading European Immunochemistry National Markets: Revenue ($bn) and Market Shares (%), 2015
  • Table 6.4 The European Immunochemistry Market Forecast ($bn), AGR (%) and CAGR (%) by leading Countries, 2015-2026
  • Table 7.1 Roche: Net sales ($bn) and Net Sales Shares (%) by Sector, 2015
  • Table 7.2 Roche Diagnostics: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
  • Table 7.3 Roche: Historic Product Launches in the Immunochemistry Market,
  • Table 7.4 Siemens: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
  • Table 7.5 Siemens Healthcare: Net Sales ($bn) by Sector, 2015
  • Table 7.6 Siemens: R&D Expenses ($bn), 2014 & 2015
  • Table 7.7 Abbott: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
  • Table 7.8 Danaher: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
  • Table 7.9 Danaher: Immunochemistry Analysers
  • Table 7.10 Johnson & Johnson Net sales ($bn) and Net Sales Shares (%) by Segment, 2015
  • Table 7.11 Ortho Clinical Diagnostics: Immunodiagnostic Analysers
  • Table 7.12 bioMérieux: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
  • Table 7.13 bioMérieux: Net Sales ($bn) and Net Sales Shares (%) by Technology, 2015
  • Table 8.1 SWOT Analysis of the Immunochemistry Market, 2016
  • Table 9.1 Immunochemistry Market Forecast ($bn, %) by Segments, 2015, 2020, 2026

List of Figures

  • Figure 3.1 Immunochemistry Market: Revenue ($bn) by Segment, 2016
  • Figure 3.2 Immunochemistry Market: Market Shares (%) by Segment, 2016
  • Figure 3.3 Global Immunochemistry Market Forecast ($bn), 2015-2026
  • Figure 4.1 Global Immunochemistry Reagents and Test Kits Market: Revenue ($bn) by Segment, 2016
  • Figure 4.2 Global Immunochemistry Reagents and Test Kits Market: Market Shares (%) by Segment, 2016
  • Figure 4.3 Disease Specific Tests Market: Revenue ($bn) by Segment, 2016
  • Figure 4.4 Disease Specific Tests Market: Market Shares (%) by Segment, 2016
  • Figure 4.5 Infectious Disease Tests Market Forecast ($bn), 2015-2026
  • Figure 4.6 Autoimmune Disease Tests Market Forecast ($bn), 2015-2026
  • Figure 4.7 Tumour Marker Market Forecast ($bn), 2015-2026
  • Figure 4.8 Cardiac Marker Market Forecast ($bn), 2015-2026
  • Figure 4.9 Allergic Blood Tests Market Forecast ($bn), 2015-2026
  • Figure 4.10 Rapid Tests Market Forecast ($bn), 2015-2026
  • Figure 4.11 Drugs of Abuse/Toxicology Market Forecast ($bn), AGR (%), 2015-2026
  • Figure 4.12 Endocrinology Tests Market Shares (%) by Segment, 2015
  • Figure 4.13 Endocrinology Tests Market Forecast ($m), 2015-2026
  • Figure 4.14 Thyroid and Fertility Tests Market Forecast ($m), 2015-2026
  • Figure 4.15 Therapeutic Drug Monitoring Market Forecast ($bn), 2015-2026
  • Figure 4.16 Anaemia/Vitamin Tests Market Forecast ($bn), 2015-2026
  • Figure 5.1 Immunochemistry Analysers Market: Revenue ($bn) by Segment, 2015
  • Figure 5.2 Chemiluminescence Analysers Market Forecast ($bn), 2015-2026
  • Figure 5.3 Immunochemistry Analysers Market Forecast ($bn) by Segment, 2015-2026
  • Figure 6.1 Immunochemistry Market: Revenue ($bn) in Leading National Markets, 2015
  • Figure 6.2 Immunochemistry Market: Market Shares (%) in Leading National Markets, 2015
  • Figure 6.3 US Immunochemistry Market Forecast ($bn), 2015-2026
  • Figure 6.4 US Survey of Illicit Drug Use Among People Aged 12 or Older: Numbers (Million), One Month in 2011
  • Figure 6.5 The Leading European Immunochemistry National Markets: Revenue ($bn), 2015
  • Figure 6.6 The Leading European Immunochemistry National Markets: European Market Shares (%), 2015
  • Figure 6.7 The European Immunochemistry Market Forecast ($bn), 2015-2026
  • Figure 6.8 Immunochemistry Market Forecast ($bn), in Germany, 2015-2026
  • Figure 6.9 Immunochemistry Market Forecast ($bn), in France, 2015-2026
  • Figure 6.10 The Italian Immunochemistry Market Forecast ($bn), 2015-2026
  • Figure 6.11 The Spanish Immunochemistry Market Forecast ($bn), 2015-2026
  • Figure 6.12 UK Immunochemistry Market Forecast ($bn), 2015-2026
  • Figure 6.13 Japanese Immunochemistry Market Forecast ($bn), 2015-2026
  • Figure 6.14 Chinese Immunochemistry Market Forecast ($bn), 2015-2026
  • Figure 6.15 Indian Immunochemistry Market Forecast ($bn), 2015-2026
  • Figure 7.1 Roche: Net Sales ($bn) by Sector, 2015
  • Figure 7.2 Roche: Net Sales Shares (%) by Sector, 2015
  • Figure 7.3 Roche Diagnostics: Net Sales ($bn) by Sector, 2015
  • Figure 7.4 Siemens: Net Sales ($bn) by Sector, 2015
  • Figure 7.5 Siemens: Net Sales Shares (%) by Sector, 2015
  • Figure 7.6 Siemens: R&D Expenses ($bn), 2014 & 2015
  • Figure 7.7 Abbott: Net Sales ($bn) by Sector, 2015
  • Figure 7.8 Abbott: Net Sales Shares (%) by Sector, 2015
  • Figure 7.10 Danaher: Net Sales ($bn) by Sector, 2015
  • Figure 7.11 Danaher: Net Sales Shares (%) by Sector, 2015
  • Figure 7.12 Johnson & Johnson: Net Sales ($bn) by Segment, 2015
  • Figure 7.13 Johnson & Johnson: Net Sales Shares (%) by Segment, 2015
  • Figure 7.14 bioMérieux: Net Sales ($bn) by Sector, 2015
  • Figure 7.15 bioMérieux: Net Sales Shares (%) by Sector, 2015
  • Figure 7.16 bioMérieux: Net Sales ($bn) by Technology, 2015
  • Figure 7.17 bioMérieux: Net Sales Shares (%) by Technology, 2015
  • Figure 8.1 Countries with Highest Share of 60+ Population, 2016
  • Figure 9.1 Global Immunochemistry Market Forecast ($bn), 2015, 2020, 2026
  • Figure 9.2 Rapid Tests Market Forecast ($bn), 2015, 2020, 2026

Companies Listed

  • Abbott
  • Abbott Laboratories
  • AbbVie
  • AES laboratoire
  • Affymetrix
  • Agilent
  • Alere
  • American Diabetes Association
  • Argene
  • Axis-Shield PLC
  • Beckman Coulter
  • bioMérieux
  • BioReliance
  • Biotech Fund Flanders
  • Cardiovascular Care
  • Centre for Devices and Radiological Health (CDRH)
  • Centres for Disease Control and Prevention (CDC)
  • Danaher
  • Depuy
  • DiaSorin
  • eBioscience
  • Ernst and Young
  • eScreen
  • Ethicon Endosurgery
  • Eucomed
  • European Diagnostics Manufacturers Association (EDMA)
  • Food and Drug Administration (FDA) US
  • Fujirebio Diagnostics
  • Gifu University
  • Gimv
  • Goldman Sachs
  • Health Protection Agency (HPA)
  • Hycor-Agilent
  • Inova Diagnostics
  • Iris Healthcare
  • Italian National Health Service
  • J Mitra & Co
  • Johnson & Johnson
  • Lilac Medicare
  • Lyon Civil Hospitals
  • MedSciences Capital (MSC)
  • Merieux Institute
  • MP Healthcare Venture Management (MPH)
  • National Health Service (NHS)
  • Ortho Clinical Diagnostics
  • Phadia
  • Pharmaceutical and Medical Devices Agency (PMDA) Japan
  • Price Waterhouse Coopers (PWC)
  • Pronota
  • Qualigen
  • Roche
  • Royal Philips Electronics
  • The Carlyle Group
  • Shenzhen Mindray Bio-Medical Electronics Co
  • Siemens
  • Siemens Healthcare
  • Sigma- Aldrich
  • Span Diagnostics
  • State Food and Drug Administration
  • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • Suyog Diagnostics
  • Sysmex
  • Thermo Fisher Scientific
  • Transasia
  • Tulip Diagnostics
  • United Nations
  • United Nations Office on Drugs and Crime (UNODC)
  • United Nations Population Division (UNDP)
  • US National Library of Medicine (NLM)
  • Valeritas
  • Vision Care
  • World Health Organization (WHO)
Back to Top